4-Dimethoxymethylpyrimidin-2-ylamine

Catalog No. :
ACQBSV439
CAS No. :
165807-05-6
Molecular Formula :
C7H11N3O2
Molecular Weight :
169.18

IUPAC Name:4-(dimethoxymethyl)pyrimidin-2-amine

4-Dimethoxymethylpyrimidin-2-ylamine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g97%$53.00Login to see priceIn stockInquiry
100g97%$204.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Dimethoxymethylpyrimidin-2-ylamine
IUPAC Name4-(dimethoxymethyl)pyrimidin-2-amine
MDL No.MFCD05864792
Molecular FormulaC7H11N3O2
Molecular Weight169.18
SMILESCOC(C1=NC(=NC=C1)N)OC
InChI KeyOQINWXZQCAIVNK-UHFFFAOYSA-N
Synonym4-(DIMETHOXYMETHYL)-2-PYRIMIDINAMINE;4-(dimethoxymethyl)-1,2-dihydropyrimidin-2-imine;4-DIMETHOXYMETHYLPYRIMIDIN-2-YLAMINE;4-(Dimethoxymethyl)pyrimidin-2-amine;4-DIMETHOXYMETHYLPYRIMIDIN-2-YLAMINE, 95+%;2-Amino-4-(dimethoxymethyl)pyrimidine;2-Pyrimidinamine, 4-(dimethoxymethyl)-;4-DIMETHOXYMETHYLPYRIMIDIN-2-YLAMINE ISO 9001:2015 REACH
CAS No.165807-05-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACQBSV439 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBNGW740 route compound structure diagram
    ACBNGW74067751-23-9 In Stock
  2. Plus
  3. ACABXR840 route compound structure diagram
    ACABXR84050979-18-5 In Stock
  4. Then
  5. ACQBSV439 route product structure diagram
    ACQBSV439165807-05-6 In Stock
Inquiry

2. ACQBSV439 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACABXR840 route compound structure diagram
    ACABXR84050979-18-5 In Stock
  4. Then
  5. ACQBSV439 route product structure diagram
    ACQBSV439165807-05-6 In Stock
Inquiry

Comments (0)